John M. Berry, MD
Medical Oncology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
Offices
1 location
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Berry’s office at (415) 353-7100 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G52443 · Current
Licensed to practise in California · since 1984 · expires 2027-06-30 · University of Miami School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
- American Board of Internal Medicine - Medical Oncology
Medicaid work
$17,017 in 2021
Medicaid paid $17,017 for 113 billed services this clinician did in 2021, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Anoscopy; with high-resolution magnification (HRA) (eg, colposcope, operating microscope) and chemical agent enhancement, with biopsy, single or multiple | 45 | $8,897 |
| DIAGNOSTIC ANOSCOPY | 34 | $5,729 |
| Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal | 34 | $2,391 |
| 2021 | 113 | 3 | 18 | $17,017 |
| 2020 | 122 | 3 | 18 | $14,228 |
| 2019 | 207 | 3 | 18 | $20,444 |
| 2018 | 264 | 4 | 22 | $25,002 |
See the largest Medicaid services in earlier years
2020
| Anoscopy; with high-resolution magnification (HRA) (eg, colposcope, operating microscope) and chemical agent enhancement, with biopsy, single or multiple | 43 | $5,899 |
| DIAGNOSTIC ANOSCOPY | 35 | $5,324 |
| Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal | 44 | $3,005 |
2019
| Anoscopy; with high-resolution magnification (HRA) (eg, colposcope, operating microscope) and chemical agent enhancement, with biopsy, single or multiple | 97 | $13,445 |
| DIAGNOSTIC ANOSCOPY | 44 | $3,685 |
| Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal | 66 | $3,314 |
2018
| Anoscopy; with high-resolution magnification (HRA) (eg, colposcope, operating microscope) and chemical agent enhancement, with biopsy, single or multiple | 106 | $13,773 |
| DIAGNOSTIC ANOSCOPY | 76 | $7,940 |
| Cytopathology, selective cellular enhancement technique with interpretation (eg, liquid based slide preparation method), except cervical or vaginal | 42 | $2,114 |
| TISSUE EXAM BY PATHOLOGIST | 40 | $1,176 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 79% of their 14 Part D prescriptions in 2022. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2022 | 14 | None | 79% (11) | None | $131 |
| 2021 | 38 | 18 | 34% (13) | None | $17,390 |
| 2020 | 66 | 33 | 50% (33) | None | $4,226 |
| 2019 | 76 | 40 | 50% (38) | None | $14,211 |
| 2018 | 105 | 59 | 61% (64) | None | $3,321 |
| 2017 | 103 | 63 | 55% (57) | None | $5,300 |
| 2016 | 105 | 63 | 46% (48) | None | $6,882 |
| 2015 | 185 | 92 | 40% (74) | 7% | $11,354 |
| 2014 | 365 | 162 | 21% (75) | 27% | $28,830 |
| 2013 | 343 | 159 | 26% (89) | 22% | $27,375 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2020: 1 drug
| Oxycodone | 19 | $96 | $5 |
2019: 3 drugs
| Valacyclovir | 14 | $768 | $55 |
| Oxycodone | 19 | $154 | $8 |
| Hydrocodone-Acetaminophen | 13 | $123 | $9 |
2018: 3 drugs
| Oxycodone | 25 | $314 | $13 |
| Hydrocodone-Acetaminophen | 32 | $303 | $9 |
| Lorazepam | 15 | $41 | $3 |
2017: 3 drugs
| Oxycodone | 22 | $429 | $19 |
| Hydrocodone-Acetaminophen | 25 | $242 | $10 |
| Lorazepam | 16 | $58 | $4 |
2016: 3 drugs
| Hydrocodone-Acetaminophen | 20 | $458 | $23 |
| Oxycodone | 21 | $308 | $15 |
| Lorazepam | 12 | $38 | $3 |
2015: 7 drugs
| Valacyclovir | 26 | $3,850 | $148 |
| Fluorouracil | 14 | $2,739 | $196 |
| Lidocaine | 11 | $1,667 | $152 |
| Polyethylene Glycol 3350 | 13 | $467 | $36 |
| Oxycodone | 31 | $460 | $15 |
| Hydrocodone-Acetaminophen | 24 | $360 | $15 |
| Hydromorphone | 14 | $132 | $9 |
2014: 11 drugs
| Fluorouracil | 16 | $4,955 | $310 |
| Valacyclovir | 27 | $2,369 | $88 |
| Travatan Z | 11 | $1,245 | $113 |
| Prednisolone Acetate | 16 | $1,154 | $72 |
| Lidocaine | 16 | $1,024 | $64 |
| Latanoprost | 42 | $564 | $13 |
| Oxycodone | 31 | $509 | $16 |
| Hydrocodone-Acetaminophen | 25 | $390 | $16 |
| Acyclovir | 15 | $263 | $18 |
| Hydromorphone | 14 | $177 | $13 |
| Lorazepam | 15 | $51 | $3 |
2013: 9 drugs
| Imiquimod | 24 | $6,385 | $266 |
| Valacyclovir | 32 | $4,653 | $145 |
| Fluorouracil | 12 | $2,956 | $246 |
| Oxycodone | 44 | $596 | $14 |
| Latanoprost | 32 | $592 | $19 |
| Hydrocodone-Acetaminophen | 27 | $280 | $10 |
| Hydromorphone | 14 | $241 | $17 |
| Acyclovir | 15 | $177 | $12 |
| Lorazepam | 21 | $71 | $3 |
Money from drug and device companies
$48 in 2025
| 2025 | 1 | 2 | None | $48 |
| 2024 | 2 | 4 | None | $102 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| ViiV Healthcare | Rukobia | $48 | 2 payments
|
See all 2 published payments
| ViiV Healthcare | Meals · 2025-11-14 | Rukobia | $25 |
| ViiV Healthcare | Meals · 2025-01-10 | Cabenuva | $22 |
See earlier years (2024)
2024: $102
| ViiV Healthcare | Cabenuva | $71 | 3 payments
|
| Merck Sharp & Dohme | Pifeltro | $30 | 1 payment
|
Professional record
- NPI
- 1942236997
- Licence
- CA G52443California G52443: Current · expires 2027-06-30
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G524430
- Taxonomy
- Medical oncology (207RX0202X); Internal medicine (207R00000X)
- Mailing address
- 1635 Divisadero Street, Suite 625, Box 1821, San Francisco, CA, 94143
- NPI first listed
- 2006-06-23
- NPI last updated
- 2025-09-11
This is when the NPI record was last certified, not a medical board exam.